FDA
-
-
-
-
-
-
-
Magdalena Biosciences coca extract prevents weight gain in mice
-
-
-
-
-
-
-
Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA)
-
-
-
-
-
-
-
Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
-
-
-
-
-
-
-
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression
-
-
-
-
-
-
-
Jaguar Health signs $38 million license deal with Future Pak
-
-
-
-
-
-
-
FDA extends approval for Jaguar Health's dog diarrhea drug through 2026
-
-
-
-
-
-
-
In Support of Possible Expedited Approval Pathway for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID), Jaguar Health Submits Amended Protocol to FDA for Ongoing Placebo-Controlled Cli
-
325,297 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All
